Becker A, Decker A, Fl xf3 rez Grau G, Bakdash G, R xf6 ring R, Stelloo S, et al. Inhibition of CSF-1R and IL-6R prevents conversion of cDC2s into immune incompetent tumor-induced DC3s boosting DC-driven therapy potential. Cell Rep Med. 2024;5:101386 pubmed publisher

Lerrer S, Tocheva A, Bukhari S, Adam K, Mor A. PD-1-stimulated T cell subsets are transcriptionally and functionally distinct. iScience. 2021;24:103020 pubmed publisher

Tocheva A, Lerrer S, Mor A. In Vitro Assays to Study PD-1 Biology in Human T Cells. Curr Protoc Immunol. 2020;130:e103 pubmed publisher

Kim A, Han C, Driver I, Olow A, Sewell A, Zhang Z, et al. LILRB1 Blockade Enhances Bispecific T Cell Engager Antibody-Induced Tumor Cell Killing by Effector CD8+ T Cells. J Immunol. 2019;203:1076-1087 pubmed publisher